Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise with key data readouts expected in 2025ORX750 Phase 2a ...

The Company continues to make steady progress toward commercial readiness, and key clinical and regulatory milestones on the ...

The list of potential controls was split by age and gender in an excel sheet. A number from 0 to 1 was automatically ... which is a transversal limitation/difficulty in all ECG studies in the PD ...

Detailed price information for Cassava Sciences Inc (SAVA-Q) from The Globe and Mail including charting and trades.

A study conducted by researchers at the University of Melbourne and NORCE Norway Research Centre has found that melting Antarctic ice sheets are slowing down the world’s largest ocean current, the ...

“Erivo’s response was a study in control,” the expert explained ... follow Showbiz Cheat Sheet’s Instagram.